Enregistrement :
5
de
20
(2018-11-15
à
2019-09-17)
Politique ou Programme
Advocate for the implementation of a diabetes and obesity strategy at a federal level, to be cascaded down at a provincial level, to ensure better prevention, diagnosis and treatment of people with metabolic diseases (obesity, pre-diabetes, diabetes)
Support the establishment of a life sciences strategy in Canada
Politique ou Programme, Proposition législative, Projet de loi ou résolution, Règlement
NAFTA negotiations and their impact on the life sciences industry
Proposition législative, Projet de loi ou résolution, Règlement
Canada European Trade Agreement Implementation (formerly Bill-C30), with respect to patent term restoration via Certificates of Supplementary Protection (CSP) and changes to Canada’s linkage regime for the pharmaceutical industry
Patented Medicines Price Review Board Reform, with regard to the change of mandate (affordability vs. excessive pricing) the basket of countries, R&D calculation, the unintended consequences of these changes on the industry and provincial investments
Subvention, Contribution ou autre avantage financier
Innovation agenda for the life sciences sector and implementation of superclusters, Strategic Innovation Fund